SCHEMBL30699586

SCHEMBL30699586

Fc1cc(F)c2nc(Cl)nc(Cl)c2c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31491045 0.81 — —
SCHEMBL30699627 0.77 APP (0.31) —
SCHEMBL31490996 0.76 — —
SCHEMBL38659674 0.74 — —
SCHEMBL31491032 0.73 — —
SCHEMBL25298536 0.72 POLB (0.31) —
SCHEMBL30157376 0.72 POLB (0.31) —
SCHEMBL29937089 0.72 APP (0.31) —
SCHEMBL24663897 0.72 — —
SCHEMBL31412230 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023244713-A1 QUINAZOLINE DERIVATIVES, COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
Send feedback